Cargando…
PFC@O(2) Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC
As a typical hallmark of solid tumors, hypoxia affects the effects of tumor radiotherapy, chemotherapy, and photodynamic therapy. Therefore, targeting the hypoxic tumor microenvironment (TME) is a promising treatment strategy for cancer therapy. Here, we prepared an Albumin Human Serum (HSA)-coated...
Autores principales: | Lan, Zhou, Zou, Ke-Long, Cui, Hao, Chen, Hao, Zhao, Yu-Yue, Yu, Guang-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862098/ https://www.ncbi.nlm.nih.gov/pubmed/36675491 http://dx.doi.org/10.3390/jcm12020560 |
Ejemplares similares
-
ASC modulates HIF-1α stability and induces cell mobility in OSCC
por: Wu, Chi-Sheng, et al.
Publicado: (2020) -
Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer
por: Ho, Teresa, et al.
Publicado: (2021) -
Letter to the editor: is HIF-1α a viable prognostic indicator in OSCC? A critical review of a meta-analysis study
por: Jayaraj, Rama, et al.
Publicado: (2018) -
Crosstalk among m(6)A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
por: Zhang, Fusheng, et al.
Publicado: (2022) -
Transanal TME – really needed?
por: Dapri, Giovanni
Publicado: (2017)